首页 正文

Review Advanced drug delivery reviews. 2009 Aug 10;61(10):863-70. doi: 10.1016/j.addr.2009.04.013 Q117.62025

Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease

女性与心脏病:基因传递和表达的生理调节:治疗缺血性心脏疾病的生物可降解聚合物和心肌梗死感应型基因疗法 翻译改进

James W Yockman  1, Sung Wan Kim, David A Bull

作者单位 +展开

作者单位

  • 1 Dept of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA.
  • DOI: 10.1016/j.addr.2009.04.013 PMID: 19422868

    摘要 Ai翻译

    Ischemic heart disease (IHD) is the leading cause of death in the United States today. This year over 750,000 women will have a new or recurrent myocardial infarction. Currently, the mainstay of therapy for IHD is revascularization. Increasing evidence, however, suggests that revascularization alone is insufficient for the longer-term management of many patients with IHD. To address these issues, innovative therapies that extend beyond revascularization to protection of the myocyte and preservation of ventricular function are required. The emergence of gene therapy and proteomics offers the potential for innovative prophylactic and treatment strategies for IHD. The goal of our research is to develop therapeutic gene constructs for the treatment of myocardial ischemia that are clinically safe and effective. Toward this end, we describe the development of physiologic regulation of gene delivery and expression using bioreducible polymers and ischemia-inducible gene therapies for the potential treatment of ischemic heart disease in women.

    Keywords:heart disease; gene delivery; bioreducible polymers

    Copyright © Advanced drug delivery reviews. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Advanced drug delivery reviews

    缩写:ADV DRUG DELIVER REV

    ISSN:0169-409X

    e-ISSN:1872-8294

    IF/分区:17.6/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease